Lee Josephson
#153,594
Most Influential Person Now
Researcher
Lee Josephson's AcademicInfluence.com Rankings
Lee Josephsonengineering Degrees
Engineering
#6307
World Rank
#7624
Historical Rank
Electrical Engineering
#1858
World Rank
#1960
Historical Rank
Lee Josephsoncomputer-science Degrees
Computer Science
#8259
World Rank
#8684
Historical Rank
Computational Linguistics
#1806
World Rank
#1825
Historical Rank
Machine Learning
#3334
World Rank
#3374
Historical Rank
Artificial Intelligence
#3635
World Rank
#3687
Historical Rank
Download Badge
Engineering Computer Science
Lee Josephson's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lee Josephson Influential?
(Suggest an Edit or Addition)Lee Josephson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. (1990) (984)
- High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. (1999) (856)
- Cell-specific targeting of nanoparticles by multivalent attachment of small molecules (2005) (849)
- Magnetic relaxation switches capable of sensing molecular interactions (2002) (789)
- Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. (1977) (765)
- A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. (2002) (547)
- A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. (2003) (545)
- Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. (1990) (484)
- A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. (1978) (451)
- Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. (2003) (446)
- Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle (2005) (439)
- Multivalent effects of RGD peptides obtained by nanoparticle display. (2006) (366)
- Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. (2002) (365)
- In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. (2003) (364)
- Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. (2004) (363)
- DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents. (2002) (318)
- Magnetic Nanosensors for the Detection of Oligonucleotide Sequences. (2001) (314)
- Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. (2002) (302)
- Magnetic Nanoparticle Sensors (2009) (276)
- Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. (2002) (263)
- Nanoparticle imaging of integrins on tumor cells. (2006) (241)
- Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle (2005) (238)
- Improvement of MRI probes to allow efficient detection of gene expression. (2000) (237)
- Use of Magnetic Nanoparticles as Nanosensors to Probe for Molecular Interactions (2004) (228)
- Isolation of a potent (Na-K)ATPase inhibitor from striated muscle. (1977) (224)
- Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. (2001) (221)
- Near-infrared fluorescent imaging of tumor apoptosis. (2003) (218)
- Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. (2002) (208)
- The transferrin receptor: a potential molecular imaging marker for human cancer. (2003) (208)
- The effects of iron oxides on proton relaxivity. (1988) (204)
- Magnetic sensors for protease assays. (2003) (204)
- Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo (2007) (203)
- The state of nanoparticle-based nanoscience and biotechnology: progress, promises, and challenges. (2012) (199)
- Magneto/optical annexin V, a multimodal protein. (2004) (198)
- High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis (2010) (166)
- Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. (2002) (162)
- Chemistry for Positron Emission Tomography: Recent Advances in 11 C-, 18 F-, 13 N-, and 15 O-Labeling Reactions. (2019) (160)
- Human transferrin receptor gene as a marker gene for MR imaging. (2001) (156)
- Novel Nanosensors for Rapid Analysis of Telomerase Activity (2004) (148)
- Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles (2006) (146)
- Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. (2006) (145)
- Annexin V–CLIO: A Nanoparticle for Detecting Apoptosis by MRI (2002) (136)
- Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO (2018) (130)
- Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. (2003) (126)
- Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. (2003) (123)
- A dual fluorochrome probe for imaging proteases. (2004) (121)
- High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. (2002) (119)
- Experimental lymph node metastases: enhanced detection with MR lymphography. (1989) (114)
- Arabinogalactan for hepatic drug delivery. (1994) (114)
- Annexin V–CLIO: A Nanoparticle for Detecting Apoptosis by MRI (2002) (108)
- Magnetic relaxation switch immunosensors detect enantiomeric impurities. (2004) (100)
- Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc02778g Click here for additional data file. (2014) (100)
- Development of nanoparticle libraries for biosensing. (2006) (98)
- Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers (2005) (96)
- Protamine as an efficient membrane-translocating peptide. (2005) (93)
- Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed-Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes In Vivo: Potential for Midmyocardial Salvage in Acute Ischemia (2009) (92)
- Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles. (2009) (89)
- Magnetic separations in biotechnology (1983) (88)
- Detection of lymph node metastases by contrast‐enhanced MRI in an experimental model (2002) (86)
- Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells (2004) (86)
- Fluorescent nanoparticle uptake for brain tumor visualization. (2006) (85)
- Sensitive NMR sensors detect antibodies to influenza. (2008) (84)
- Boron agents for neutron capture therapy (2020) (84)
- Environment-responsive Nanophores for Therapy and Treatment Monitoring via Molecular MRI Quenching (2014) (83)
- A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. (1990) (82)
- Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. (1994) (78)
- Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation. (2008) (76)
- “Clickable” Nanoparticles for Targeted Imaging (2006) (75)
- Multiparameter magnetic relaxation switch assays. (2007) (74)
- Nanoparticle-target interactions parallel antibody-protein interactions. (2009) (70)
- Nanoparticles for the optical imaging of tumor E-selectin. (2005) (70)
- Continuous analyte sensing with magnetic nanoswitches. (2006) (67)
- Reaction of (Na-K)ATPase with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: evidence for an essential tyrosine at the active site. (1978) (64)
- Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide. (2011) (64)
- Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. (2008) (63)
- Magnetic relaxation switch detection of human chorionic gonadotrophin. (2007) (59)
- Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography. (2009) (55)
- Molecular MRI of acute necrosis with a novel dna-binding gadolinium chelate: kinetics of cell death and clearance in infarcted myocardium (2011) (54)
- Method of determining nanoparticle core weight. (2005) (53)
- Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure (2009) (52)
- Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. (2011) (50)
- Recent developments on PET radiotracers for TSPO and their applications in neuroimaging (2020) (48)
- Cell Internalization of Magnetic Nanoparticles Using Transfection Agents (2007) (47)
- Fluorescent and radiolabeled triphenylphosphonium probes for imaging mitochondria. (2013) (46)
- Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer. (2011) (45)
- Optimal Modification of Annexin V with Fluorescent Dyes (2004) (45)
- Methotrexate-Induced Accumulation of Fluorescent Annexin V in Collagen-Induced Arthritis (2005) (40)
- Transfection Agent Induced Nanoparticle Cell Loading (2005) (39)
- Integrated nanosensors to determine levels and functional activity of human telomerase. (2008) (39)
- Fluorescence Tomography of Rapamycin-Induced Autophagy and Cardioprotection In Vivo (2013) (37)
- A DNA-binding Gd chelate for the detection of cell death by MRI. (2009) (37)
- Conjugation of adenine arabinoside 5'-monophosphate to arabinogalactan: synthesis, characterization, and antiviral activity. (1995) (37)
- The magnetic properties of some materials affecting MR images (1991) (37)
- Simplified syntheses of complex multifunctional nanomaterials. (2008) (36)
- Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. (2003) (36)
- Multimodal Interventional Molecular Imaging of Tumor Margins and Distant Metastases by Targeting αvβ3 Integrin (2012) (36)
- Heat-induced radiolabeling and fluorescence labeling of Feraheme nanoparticles for PET/SPECT imaging and flow cytometry (2018) (34)
- Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors. (2018) (33)
- Electrode chemistry yields a nanoparticle-based NMR sensor for calcium. (2008) (32)
- The PEG-fluorochrome shielding approach for targeted probe design. (2012) (32)
- Ratio imaging of enzyme activity using dual wavelength optical reporters. (2002) (32)
- Magnetic Nanoparticles for MR Imaging (2006) (31)
- Covalent reactions of wortmannin under physiological conditions. (2007) (30)
- Fluorochrome-functionalized nanoparticles for imaging DNA in biological systems. (2013) (30)
- Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET. (2015) (29)
- Facile Synthesis of Monofunctional Pentamethine Carbocyanine Fluorophores. (2011) (29)
- Ouabain reaction with microsomal (sodium-plus-potassium)-activated adenosinetriphosphatase. Characteristics of substrate and ion dependencies. (1972) (28)
- Magnetic microparticle aggregation for viscosity determination by MR (2008) (27)
- Multispectral visualization of surgical safety-margins using fluorescent marker seeds. (2012) (27)
- Imaging of apoptosis in the heart with nanoparticle technology. (2011) (26)
- A slow interconversion between active and inactive states of the (Na-K)ATPase. (1976) (26)
- Fluorochrome-functionalized magnetic nanoparticles for high-sensitivity monitoring of the polymerase chain reaction by magnetic resonance. (2012) (26)
- Barriers to Clinical Translation with Diagnostic Drugs (2013) (26)
- Design, Synthesis, and Evaluation of Reversible and Irreversible Monoacylglycerol Lipase Positron Emission Tomography (PET) Tracers Using a "Tail Switching" Strategy on a Piperazinyl Azetidine Skeleton. (2019) (22)
- Visualization of superior mesenteric lymph nodes by the combined oral and intravenous administration of the ultrasmall superparamagnetic iron oxide, AMI-227. (1994) (21)
- U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform (2014) (21)
- Independent magnetic switching units in cobalt-doped iron oxide particles (1986) (21)
- Use of a Single Hybrid Imaging Agent for Integration of Target Validation with In Vivo and Ex Vivo Imaging of Mouse Tumor Lesions Resembling Human DCIS (2013) (20)
- Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury (2017) (20)
- Fluorescein isothiocyanate-hapten immunoassay for determination of peptide-cell interactions. (2004) (17)
- Synthesis and activity of C11-modified wortmannin probes for PI3 kinase. (2005) (17)
- Biologically degradable superparamagnetic materials for use in clinical applications (1991) (16)
- Fate of a bioactive fluorescent wortmannin derivative in cells. (2008) (16)
- A magnetofluorescent nanoparticle for ex-vivo cell labeling by covalently linking the drugs protamine and Feraheme. (2011) (16)
- The antiproliferative cytostatic effects of a self-activating viridin prodrug (2009) (16)
- A screening paradigm for the design of improved polymer-coated superparamagnetic iron oxide nanoparticles (2009) (16)
- Quantitative endovascular fluorescence-based molecular imaging through blood of arterial wall inflammation. (2009) (16)
- Multiparameter noninvasive assessment of treatment susceptibility, drug target inhibition and tumor response guides cancer treatment (2007) (15)
- Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterials (2017) (15)
- Divergent oriented synthesis for the design of reagents for protein conjugation. (2010) (15)
- Enzyme-based visualization of receptor–ligand binding in tissues (2006) (14)
- Stability of dilute solutions of gentamicin and tobramycin. (1979) (14)
- Use of AMI-227 as an oral MR contrast agent. (1994) (13)
- Design, Synthesis and Evaluation of 18F-labeled Monoacylglycerol Lipase Inhibitors as Novel Positron Emission Tomography Probes. (2019) (13)
- Fluorescent Nanoparticle Imaging Allows Noninvasive Evaluation of Immune Cell Modulation in Esophageal Dysplasia (2014) (13)
- High Efficiency Diffusion Molecular Retention Tumor Targeting (2013) (13)
- The slow cell death response when screening chemotherapeutic agents (2011) (13)
- In Vitro Evaluation of [3H]CPPC as a Tool Radioligand for CSF-1R. (2021) (12)
- Stability of prostatic acid posphatase in normal human sera. (1980) (12)
- Slow self-activation enhances the potency of viridin prodrugs. (2008) (12)
- Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function. (2009) (11)
- Synthesis and Preliminary Evaluation of [11C]GNE‐1023 as a Potent PET Probe for Imaging Leucine‐Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease (2019) (11)
- Synthesis, pharmacology and preclinical evaluation of 11C-labeled 1,3-dihydro-2H-benzo[d]imidazole-2-ones for imaging γ8-dependent transmembrane AMPA receptor regulatory protein. (2018) (11)
- Protective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5. (2012) (9)
- Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain. (2019) (9)
- A stabilized demethoxyviridin derivative inhibits PI3 kinase. (2009) (9)
- Effects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model (2015) (9)
- Quantitative Measurement of Protease-Activity with Correction of Probe Delivery and Tissue Absorption Effects. (2009) (9)
- Molecular MR Imaging Probes (2005) (9)
- An automated assay for NaK ATPase kinetics (1974) (9)
- Theranostic Imaging of the Kinases and Proteases that Modulate Cell Death and Survival (2012) (9)
- Quantitative Analysis of Chemotherapeutic Effects in Tumors Using In Vivo Staining and Correlative Histology (2005) (8)
- Imaging DNA with fluorochrome bearing metals. (2013) (8)
- An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy (2017) (8)
- [18F]- Alfatide PET imaging of integrin αvβ3 for the non-invasive quantification of liver fibrosis. (2020) (8)
- A Radio-Nano-Platform for T1/T2 Dual-Mode PET-MR Imaging (2020) (8)
- Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery. (2021) (8)
- Contrast agents for magnetic resonance imaging of the liver. (1991) (7)
- A wortmannin-cetuximab as a double drug. (2009) (7)
- Molecular imaging of cell-based therapies. (2004) (7)
- PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease (2019) (7)
- Arabinogalactan (9kDa)-9-β-D-Arabinofuranosyladenine-5′-Monophosphate, A Novel Liver-Targeted Conjugate that Selectively Inhibits Hepatitis B virus Replication in Vitro (1997) (6)
- Synthesis and Preliminary Evaluation of 11C‐Labeled VU0467485/AZ13713945 and Its Analogues for Imaging Muscarinic Acetylcholine Receptor Subtype 4 (2018) (6)
- Synthesis and preliminary evaluation of novel 11C-labeled GluN2B-selective NMDA receptor negative allosteric modulators (2020) (6)
- A multifunctional single-attachment-point reagent for controlled protein biotinylation. (2009) (6)
- A Chelate-Free Nano-Platform for Incorporation of Diagnostic and Therapeutic Isotopes (2020) (6)
- The Binding of BF-227-Like Benzoxazoles to Human α-Synuclein and Amyloid β Peptide Fibrils (2018) (5)
- Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents (1989) (5)
- The use of AMI-227 as an oral contrast agent for magnetic resonance imaging. (1994) (5)
- Antiviral activity of a conjugate of adenine-9-beta-D-arabinofuranoside 5'-monophosphate and a 9 kDa fragment of arabinogalactan. (1996) (5)
- Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models. (2015) (5)
- A Novel Dual Fluorochrome Near-Infrared Imaging Probe for Potential Alzheimer’s Enzyme Biomarkers-BACE1 and Cathepsin D (2020) (5)
- Multiplexed Optical Imaging of Energy Substrates Reveals That Left Ventricular Hypertrophy Is Associated With Brown Adipose Tissue Activation (2018) (4)
- Development of a highly-specific 18F-labeled irreversible positron emission tomography tracer for monoacylglycerol lipase mapping (2021) (4)
- [18F]MAGL-4-11 positron emission tomography molecular imaging of monoacylglycerol lipase changes in preclinical liver fibrosis models (2021) (4)
- Magnetic Nanoparticles for Application in Biomedical Sensing (2012) (4)
- PEG-Like Nanoprobes: Multimodal, Pharmacokinetically and Optically Tunable Nanomaterials (2014) (3)
- Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using 'in-loop' [11C]CO2 fixation method. (2020) (3)
- Cytoprotective nanoparticles by conjugation of a polyhis tagged annexin V to a nanoparticle drug. (2015) (3)
- Optical Imaging of Apoptosis (2003) (3)
- Imaging Autotaxin In Vivo with 18F-Labeled Positron Emission Tomography Ligands. (2021) (3)
- Imaging Leucine-Rich Repeat Kinase 2 In Vivo with 18F-Labeled Positron Emission Tomography Ligand. (2022) (3)
- Positron annihilation localization by nanoscale magnetization (2020) (2)
- Identity of the Na Activation Sites in ATPase with the K Activation Sites in p-Nitrophenylphosphatase (1983) (2)
- MAGNETIC NANOSENSORS FOR DNA ANALYSIS (2002) (2)
- Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[11C]methoxyphenethyl)pyridazin-3(2H)-one, a 11C-labeled d-amino acid oxidase (DAAO) inhibitor for PET imaging. (2020) (2)
- Synthesis and Activity of C 11-Modified Wortmannin Probes for PI 3 Kinase (2)
- A nanoparticle probe for the imaging of autophagic flux in live mice via magnetic resonance and near-infrared fluorescence (2022) (2)
- Author Correction: Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching (2019) (1)
- A novel monoacylglycerol lipase-targeted 18F-labeled probe for positron emission tomography imaging of brown adipose tissue in the energy network (2022) (1)
- Pan and Sentinel Lymph Node Visualization Using a Near-Infrared Fluorescent Probe (2003) (1)
- Synthesis and preliminary evaluation of 18F-labeled 1-(6,7-dimethyl-4-(methylamino)-1,3-dihydro-2H-pyrrolo[3,4-c]pyridin-2-yl)-2-(trans-2-(6-fluoropyridin-3-yl)cyclopropyl)ethan-1-one for imaging muscarinic acetylcholine receptor subtype 4 (2020) (1)
- Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging (1991) (1)
- Abstract 1724: MRI Enhanced with Magnetic Nanoparticles Measures Inflammatory Burden in Atherosclerosis In Vivo (2006) (1)
- Biodegradable superparamagnetic material for use in clinical applications (1987) (1)
- Hybrid peptide dendrimers for imaging of CXCR4 expression (2013) (1)
- An automated assay for Na-K ATPase kinetics. (1974) (1)
- Patents and literature (1985) (1)
- ion binding and heat-induced radiolabeling of iron oxide nanoparticles † (2014) (1)
- Synthesis and evaluation of 6-(11C-methyl(4-(pyridin-2-yl)thiazol-2-yl)amino)benzo[d]thiazol-2(3H)-one for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein by PET. (2019) (1)
- A New Platform for the Development of Targeted MR Contrast Agents 1 (2002) (1)
- Fluorescent nanoparticle imaging allows noninvasive evaluation of immune cell modulation in esophageal dysplasia. (2014) (1)
- 5314679 Vascular magnetic resonance imaging agent comprising nanoparticles (1995) (0)
- Radiosynthesis and preclinical evaluation of a novel 18F-labeled MAGL inhibitor PF-06795071 for MAGL imaging (2019) (0)
- Radiosynthesis and Preclinical Evaluation of [11C]PF-06447475 for LRRK2 imaging (2019) (0)
- Chemical and biological kinetics of click chemistry reactions for surface modification of Feraheme nanoparticles (2019) (0)
- PET/CT imaging of macrophage infiltration in myocardial infarct with 89Zr-Ferumoxytol (2014) (0)
- Using with polysaccharidic coated superparamagnetic oxide colloid (1993) (0)
- Materiaux superparamagnetiques biodegradables destines a des applications cliniques (1987) (0)
- An Integrin-Targeted, Highly Diffusive Construct for Photodynamic Therapy (2017) (0)
- Particles which are responsive to magnetism, process for their preparation and their use for determining and isolating ligates (1984) (0)
- PEG-like nanoprobes are long circulating, renally eliminated nanomaterials for SPECT imaging (2014) (0)
- Ultrasensitive DNA detection in biological systems using Magnetic fluorochrome nanoparticles (2012) (0)
- Devices for Nanoparticle-based Cancer Detection (2007) (0)
- The Magnetic Properties of Some Materials Affecting Magnetic Resonance Images (1991) (0)
- Radiosynthesis of 6-(2-cyclobutyl-5-[11C]methyl-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one as a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein (2019) (0)
- Use of coated with polysaccharides superparamagnetic oxide colloids (1993) (0)
- The Development of Non-Radiative Probes for In Vivo Applications (2003) (0)
- Method of Determining Nanoparticie Core Weight (2005) (0)
- Abstract 16931: Multiplexed Optical Imaging of Energy Metabolism in Brown Adipose Tissue in a Model of LV Hypertrophy (2016) (0)
- Multimodal nanoprobes with pharmacokinetic and radiometal tunablity for SPECT or PET imaging (2014) (0)
- Vascular magnetic image deformation process (1989) (0)
- Abstract 434: Acidifying Nanoparticle Upregulates Autophagy and Enhances Cardiomyocyte Survival after Chemotherapy (2019) (0)
- PEG-like multimodal nanoprobes as imaging agents (2013) (0)
- Abstract 1107: Labeling With a Novel Magnetofluorescent Molecular Imaging Probe Does Not Affect the Proliferation and Cardiomyogenic Potential of Cardiac Side Population Progenitor Cells (2007) (0)
- Efficient radiosynthesis and preliminary autoradiography evaluation of a potent 11C-labeled LRRK2 inhibitor (2019) (0)
- Preliminary evaluation of [11C]MAGL-0519 as a promising PET ligand for the diagnosis of Hepatocellular carcinoma. (2022) (0)
- By a receptor-induced contrast agent for the endocytic type mri (1989) (0)
- Nanoparticle-based Cancer Biomarker Sensor (2007) (0)
- Sensitive NMR Sensors Detect Antibodies to Influenza how this access benefits you. Your story matters (2009) (0)
- In the near-infrared region fluorescent probes that are quenchiert intramolecular (1999) (0)
- Karbohydrate low molecular weight as an additive for the stabilization of metal oxide compounds (1991) (0)
- Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cardioprotective Effects in Ischemia Reperfusion Injury Murine Model (2016) (0)
- Synthesis and preliminary evaluation of novel 11C-labeled GluN2B-selective NMDA receptor negative allosteric modulators (2020) (0)
- Author Correction: Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching (2019) (0)
- Method of carrying out enzymatic reaction (1994) (0)
- 5164297 Solvent mediated relaxation assay system (1993) (0)
- FILTER STERILIZATION FOR PREPARING COLLOIDAL superparamagnetic MR CONTRAST AGENTS and their use (1991) (0)
- Quantitative mapping of cardiac membrane potential: A feasibility study (2015) (0)
- Heat-induced, chelate-free radiolabeling of iron-oxide nanoparticles (2014) (0)
- Towards imaging guided surgical intervention by applying an alpha v beta 3 integrin targeted multimodal imaging agent (2011) (0)
- Positron Emission Tomography (PET) Imaging of Metabotropic Glutamate Receptor Subtype 2 (mGlu2) Based on a Negative Allosteric Modulator Radioligand (2021) (0)
- Severe toxicity of fialuridine (FIAU) (1996) (0)
- A combination of heat induced radiolabeling and click surface modification repurposes feraheme as multifunctional nanoparticles for PET/SPECT imaging agents (2017) (0)
- Front Cover: Synthesis and Preliminary Evaluation of 11 C‐Labeled VU0467485/AZ13713945 and Its Analogues for Imaging Muscarinic Acetylcholine Receptor Subtype 4 (ChemMedChem 3/2019) (2019) (0)
- 5254460 Solvent mediated relaxation assay system (1994) (0)
- Abstract 3024: Sensitivity of Molecular MRI for Low Levels of Cardiomyocyte Apoptosis in an In-Vivo Model of Dilated Cardiomyopathy (2006) (0)
- Design, synthesis and evaluation of reversible and irreversible monoacylglycerol lipase PET tracers using a ‘tail-switching’ strategy on a piperazinyl azetidine skeleton (2019) (0)
- Ratio Imaging of Enzyme Activity Using Dual Wavelength Optical Reporters (2002) (0)
- An MR Contrast Agent for Intra-Prostatic Imaging of Prostatic Cancer (2005) (0)
- Opti-SPECT: Preclinical module for integrated bioluminescence, fluorescence and radionuclide imaging (2014) (0)
- Multimodal molecular imaging of tumor margins and distant metastases guided by alpha(v)beta(3) integrin expression (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lee Josephson?
Lee Josephson is affiliated with the following schools:
